Incidence of Stevens-Johnson syndrome/toxic epidermal necrolysis among new users of different individual drugs in a European population: a case-population study-Reference-Cited by-同舟云学术

Incidence of Stevens-Johnson syndrome/toxic epidermal necrolysis among new users of different individual drugs in a European population: a case-population study

Published:2018-10-08 Issue:2 Volume:75 Page:237-246
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

Rodríguez-Martín Sara,Martín-Merino Elisa,Lerma Victoria,Rodríguez-Miguel Antonio,González Olga,González-Herrada Carlos,Ramírez Elena,Bellón Teresa,de Abajo Francisco J.

Funder

Instituto de Salud Carlos III

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://link.springer.com/article/10.1007/s00228-018-2569-3/fulltext.html

Reference34 articles.

1. Heng YK, Lee HY, Roujeau JC (2015) Epidermal necrolysis: 60 years of errors and advances. Br J Dermatol 173:1250–1254

2. Diphoorn J, Cazzaniga S, Gamba C, Schroeder J, Citterio A, Rivolta AL, Vighi GD, Naldi L, REACT-Lombardia study group (2016) Incidence, causative factors and mortality rates of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in northern Italy: data from the REACT registry. Pharmacoepidemiol Drug Saf 25:196–203

3. Sekula P, Dunant A, Mockenhaupt M, Naldi L, Bouwes Bavinck JN, Halevy S, Kardaun S, Sidorodd A, Liss Y, Schumacher M, Roujeau JC, RegiSCAR syudy group (2013) Comprehensive survival analysis of a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis. J Investig Dermatol 133:1197–1204